Skip To Main Content Skip To Profile Details
A researcher wearing blue latex gloves works with bacterial colonies in a petri dish with a rack of test tubes and other laboratory supplies shown in the background
Image: Getty Images

Antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), have become a rapidly growing threat to public health. Each year, they account for more than 2.8 million related infections, according to the Centers for Disease Control. Without new antibiotics, even common injuries and infections harbor the potential to become lethal.

Scientists are now one step closer to eliminating that threat, thanks to a Texas A&M University-led collaboration that has developed a new family of polymers capable of killing bacteria without inducing antibiotic resistance by disrupting the membrane of these microorganisms.

“The new polymers we synthesized could help fight antibiotic resistance in the future by providing antibacterial molecules that operate through a mechanism against which bacteria do not seem to develop resistance,” said Dr. Quentin Michaudel, an assistant professor in the Department of Chemistry and lead investigator in the research, published Dec. 11 in the Proceedings of the National Academy of Sciences (PNAS).

Working at the interface of organic chemistry and polymer science, the Michaudel Laboratory was able to synthesize the new polymer by carefully designing a positively charged molecule that can be stitched many times to form a large molecule made of the same repeating charged motif using a carefully selected catalyst called AquaMet. According to Michaudel, that catalyst proves key, given that it has to tolerate a high concentration of charges and also be water-soluble — a feature he describes as uncommon for this type of process.

Graphic illustrating the chemical synthesis of new charged polymers as antibacterial agents using a ruthenium catalyst
Graphical illustration of the chemical synthesis of new charged polymers as antibacterial agents using a ruthenium catalyst. | Image: Dr. Quentin Michaudel

After achieving success, the Michaudel Lab put their polymers to the test against two main types of antibiotic-resistant bacteria — E. coli and MRSA — in collaboration with Dr. Jessica Schiffman’s group at the University of Massachusetts Amherst. While awaiting those results, they also tested their polymers’ toxicity against human red blood cells.

"A common issue with antibacterial polymers is a lack of selectivity between bacteria and human cells when targeting the cellular membrane," Michaudel explained. "The key is to strike a right balance between effectively inhibiting bacteria growth and killing several types of cells indiscriminately."

Michaudel credits the multidisciplinary nature of scientific innovation and the generosity of dedicated researchers across the Texas A&M campus and country as factors equally as critical to his team’s success as determining the perfect catalyst for their molecule assembly.

“This project was several years in the making and would not have been possible without the help of several groups, in addition to our UMass collaborators,” Michaudel said. “For instance, we had to ship some samples to the Letteri Lab at the University of Virginia to determine the length of our polymers, which required the use of an instrument that few labs in the country have. We are also tremendously grateful to [biochemistry Ph.D. candidate] Nathan Williams and Dr. Jean-Philippe Pellois here at Texas A&M, who provided their expertise in our assessment of toxicity against red blood cells.”

Michaudel says the team will now focus on improving the activity of their polymers against bacteria — specifically, their selectivity for bacterial cells versus human cells — before moving on to in vivo assays.

“We are in the process of synthesizing a variety of analogs with that exciting goal in mind,” he added.

Texas A&M University chemist Quentin Michaudel (right), pictured with Michaudel Laboratory members (from left) Arunava Maity, An Tran and Sarah Hancock at Hancock's doctoral commencement on Dec. 15, 2023.
Michaudel (right), pictured with lab members (from left) Dr. Arunava Maity, An Tran and Dr. Sarah Hancock at Hancock's commencement on Dec. 15, 2023. | Image: Courtesy photo

The team’s paper, which features Michaudel Lab member and December 2023 Texas A&M chemistry Ph.D. graduate Dr. Sarah Hancock '23 as first author, can be viewed online along with related figures and captions. Other key contributors from the Michaudel Lab are chemistry graduate student An Tran '23, postdoctoral scholar Dr. Arunava Maity and former postdoctoral scholar Dr. Nattawut Yuntawattana, who is now an assistant professor of materials science at Kasetsart University in Thailand.

This research was funded primarily by Michaudel’s National Institutes of Health Maximizing Investigators’ Research Award (MIRA) through the National Institute of General Medical Sciences (Grant No. R35GM138079).

A native of La Rochelle, France, Michaudel joined the Texas A&M Chemistry faculty in 2018 and also holds a joint appointment in the Department of Materials Science and Engineering. In addition to an NIH MIRA in 2020, his career honors to date include a 2022 National Science Foundation Faculty Early Career Development (CAREER) Award, a 2022 American Chemical Society Polymeric Materials: Science and Engineering (PMSE) Young Investigator Award and a 2021 Thieme Chemistry Journals Award. 

Learn more about Michaudel and his research at https://www.michaudellab.org/.

About Research At Texas A&M University

As one of the world’s leading research institutions, Texas A&M is at the forefront in making significant contributions to scholarship and discovery, including in science and technology. Research conducted at Texas A&M generated annual expenditures of more than $1.148 billion in fiscal year 2021. Texas A&M ranked 14th in the most recent National Science Foundation’s Higher Education Research and Development Survey based on expenditures of more than $1.131 billion in fiscal year 2020. Texas A&M’s research creates new knowledge that provides basic, fundamental and applied contributions resulting, in many cases, in economic benefits to the state, nation and world. To learn more, visit Research@Texas A&M.